Huonslab Achieves Last-Patient-In (LPI) in Phase 1 Pivotal Study for Recombinant Human Natural Hyaluronidase PH20
Phase 1 Pivotal Study in Korea for HLB3-002
Plans to apply for marketing approval with the MFDS by the 2H 2025
PANGYO, South Korea, May 26, 2025--(BUSINESS WIRE)--Huonslab Co., Ltd. ("Huonslab"), a subsidiary of Huons Global (KOSDAQ:084110) has announced the successful completion of patient enrollment in its pivotal phase 1 clinical trial of Hydizyme™ (recombinant human natural hyaluronidase PH20; rHuPH20; HLB3-002), marking a significant milestone in the ongoing HLB3-002 development program. HLB3-002 Phase 1 Study (NCT06713317) was designed to evaluate the safety and allergenicity of HLB3-002 in 243 healthy volunteers.
The study is being conducted as a two-part, randomized, double-blind, placebo-controlled study. The first part focuses on evaluating allergenicity of HLB3-002 upon single intradermal administration of HLB3-002, while the second part focuses on evaluating safety of HLB3-002 upon single subcutaneous administration. The study is ongoing at four leading medical institutions in South Korea, known for their excellence in clinical research: Seoul National University Hospital, Asan Medical Center, Konkuk University Medical Center, and Chung-Ang University Hospital. The participating sites were selected to support consistent trial conduct and participant recruitment.
Huonslab expects to submit a Biological License Application (BLA) for marketing approval with the MFDS by the second half of this year, pending trial outcomes.
Huonslab's official said, "This milestone represents an important step in advancing the HLB3-002 development program. The results of this phase 1 will provide Huonslab with important insights into the safety and allergenicity profile of HLB3-002, laying a solid foundation for future clinical trials and regulatory submission."
In April, Huonslab attracted much attention at the 2025 Annual Meeting of the American Association for Cancer Research (AACR 2025), held in Chicago, when the company announced the result of formulation conversion using recombinant human hyaluronidase HLB3-002 in a poster presentation.
About Huonslab
Huonslab, a South Korean biologics R&D leader and subsidiary of Huons Global (KOSDAQ:084110), is a fast-paced Bio, Pharmaceuticals & Healthcare business holding company with more than 2,200 employees, worldwide.
Huonslab was established in 2018 to innovate human hyaluronidase-based biologics for subcutaneous (SC) delivery. Its proprietary HyDIFFUZE™ platform, manufactured with a recombinant CHO cell line and patented process, offers a patient-friendly and economical alternative to traditional intravenous (IV) delivery by streamlining SC administration of various therapeutic modalities.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250526729798/en/
Contacts
Media Contact Dr. Byung Ha LeeChief Business Officerblee@huonslab.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
27 minutes ago
- Business Wire
Alphawave Semi Tapes Out Breakthrough 36G UCIe™ IP on TSMC 2nm, Unlocking Foundational AI Platform IP on Nanosheet Processes
LONDON & TORONTO--(BUSINESS WIRE)-- Alphawave Semi (LSE: AWE), a global leader in high-speed connectivity and compute silicon for the world's technology infrastructure, announced the successful tape out of one of the industry's first UCIe™ IP subsystem on TSMC's N2 process, supporting 36G die-to-die data rates. The solution is fully integrated with TSMC's Chip-on-Wafer-on-Substrate (CoWoS ®) advanced packaging technology, unlocking breakthrough bandwidth density and scalability for next-generation chiplet architectures. This milestone builds on the recent release of the Alphawave Semi AI Platform, proving readiness to support the future of disaggregated SoCs and scale-up infrastructure for hyperscale AI and HPC workloads. With this tape-out, Alphawave Semi becomes one of the industry's first to enable UCIe connectivity on 2nm nanosheet technology, marking a major step forward for the open chiplet ecosystem. 'We're proud to lead the industry into the N2 era with the first UCIe IP on this advanced node,' said Mohit Gupta, Senior VP & GM, Custom Silicon & IP, Alphawave Semi. 'Our 36G subsystem validates a new class of high-density, power-efficient chiplet connectivity and paves the way for 64G UCIe and beyond—critical for AI and high-radix networking applications.' Alphawave Semi's one of the industry's first UCIe IP subsystem on TSMC's 2nm process delivers 36G performance with 11.8 Tbps/mm bandwidth density, ultra-low power and latency, and advanced features like live per-lane health monitoring and comprehensive testability. Compliant with UCIe 2.0 standard and supporting multi protocols, including PCIe ®, CXL™, AXI, CHI and more with Alphawave Semi's highly configurable and efficient Streaming Protocol D2D Controller. Alphawave Semi is advancing key ecosystem collaborations to enable groundbreaking technologies, leveraging D2D-based open chiplet interoperability to drive a broader AI connectivity platform for the industry. Alphawave Semi's UCIe IP on the TSMC N2 process affirms its position as one of the leading enablers of scalable, open chiplet ecosystems. 'Our latest collaboration with Alphawave Semi underscores our shared commitment to driving advancements in high-performance computing through design solutions that fully leverage the performance and energy-efficiency advantages of TSMC's advanced process and packaging technologies,' said Lipen Yuan, Senior Director of Advanced Technology Business Development at TSMC. 'This milestone illustrates how close collaboration with our Open Innovation Platform ® (OIP) partners like Alphawave Semi can enable the quick delivery of advanced interface IP and custom silicon solutions to meet the increasing demands of AI and cloud infrastructure.' Alphawave Semi is already executing on its plans to deliver next-generation UCIe solutions, with 64G UCIe support — empowering AI and HPC customers to lead in a rapidly evolving chiplet-driven landscape. About Alphawave Semi Alphawave Semi is a global leader in high-speed connectivity and compute silicon for the world's technology infrastructure. Faced with the exponential growth of data, Alphawave Semi's technology services a critical need: enabling data to travel faster, more reliably, and with higher performance at lower power. We are a vertically integrated semiconductor company, and our IP, custom silicon, and connectivity products are deployed by global tier-one customers in datacenters, compute, networking, AI, 5G, autonomous vehicles, and storage. Founded in 2017 by an expert technical team with a proven track record in licensing semiconductor IP, our mission is to accelerate the critical data infrastructure at the heart of our digital world. To find out more about Alphawave Semi, visit: Alphawave Semi and the Alphawave Semi logo are trademarks of Alphawave IP Group plc. All rights reserved.
Yahoo
40 minutes ago
- Yahoo
Babcock & Wilcox Announces Agreement to Sell Its Diamond Power International Business
- $177 million in total consideration subject to customary fees and adjustments- Industrial, utility and data center power demand is increasing globally- B&W now well-capitalized and poised to leverage growth in 2025 and beyond AKRON, Ohio, June 05, 2025--(BUSINESS WIRE)--Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE: BW) announced today that it has reached an agreement to sell its Diamond Power International business ("Diamond Power") to Austria-based ANDRITZ for $177 million, subject to customary fees and adjustments. The sale is expected to close within approximately 30 days and will include the transfer of approximately 400 employees to ANDRITZ. "B&W has had a strong start to 2025 and has achieved the highest bookings and backlog in decades from our parts and services business in addition to our already strong backlog from Thermal projects, upgrades and construction, primarily in North America," said Kenneth Young, B&W Chairman and Chief Executive Officer. "Our core parts, services and construction businesses demonstrated solid performance in Q1 and continue to excel in Q2 as the rising energy needs of data centers and industrial and utility markets fuel demand for our offerings. The sale of Diamond Power, which achieves annual revenues in the range of $110 million, will be transformational and will reinforce the value of our underlying assets as we re-capitalize our businesses going forward." "With a strong balance sheet, we are well-positioned to win new gas conversions, plant upgrades and behind-the-meter data center projects in North America and beyond," Young added. "We're also seeing additional demand for our BrightLoop™ technologies – both for steam generation and hydrogen production that can produce energy with lower costs and expenditures than other hydrogen technologies. Our unique technology – which is capable of supporting utilities and industries with low-cost hydrogen and steam generation while capturing CO2 – demonstrates the spirit of innovation and strong engineering capabilities that have driven B&W throughout its history and will be the foundation of our growth strategy for years to come." "Diamond Power provides boiler cleaning and monitoring solutions for utilities and industries around the world, and we're grateful for the decades of hard work and dedication shown by its employees," said Christopher Riker, B&W Executive Vice President and Chief Operating Officer. "We look forward to working closely with ANDRITZ to ensure a smooth transition and to our continued collaboration on boiler cleaning solutions in the future." About Babcock & Wilcox Headquartered in Akron, Ohio, Babcock & Wilcox Enterprises, Inc. is a leader in energy and environmental products and services for power and industrial markets worldwide. Follow us on LinkedIn and learn more at Forward-Looking Statements B&W cautions that this release contains forward-looking statements, including, without limitation, statements relating to an agreement to sell its Diamond Power businesses to ANDRITZ, demand for our products, future projects, and growth strategy. These forward-looking statements are based on management's current expectations and involve a number of risks and uncertainties. For a more complete discussion of these risk factors, see our filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K. If one or more of these risks or other risks materialize, actual results may vary materially from those expressed. We caution readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and we undertake no obligation to update or revise any forward-looking statement, except to the extent required by applicable law. View source version on Contacts Investor Contact:Investor RelationsBabcock & Wilcox704.625.4944investors@ Media Contact:Ryan CornellPublic RelationsBabcock & Wilcox330.860.1345rscornell@ Sign in to access your portfolio
Business Wire
an hour ago
- Business Wire
Babcock & Wilcox Announces Agreement to Sell Its Diamond Power International Business
AKRON, Ohio--(BUSINESS WIRE)--Babcock & Wilcox Enterprises, Inc. ('B&W' or the 'Company') (NYSE: BW) announced today that it has reached an agreement to sell its Diamond Power International business ('Diamond Power') to Austria-based ANDRITZ for $177 million, subject to customary fees and adjustments. The sale is expected to close within approximately 30 days and will include the transfer of approximately 400 employees to ANDRITZ. 'B&W has had a strong start to 2025 and has achieved the highest bookings and backlog in decades from our parts and services business in addition to our already strong backlog from Thermal projects, upgrades and construction, primarily in North America,' said Kenneth Young, B&W Chairman and Chief Executive Officer. 'Our core parts, services and construction businesses demonstrated solid performance in Q1 and continue to excel in Q2 as the rising energy needs of data centers and industrial and utility markets fuel demand for our offerings. The sale of Diamond Power, which achieves annual revenues in the range of $110 million, will be transformational and will reinforce the value of our underlying assets as we re-capitalize our businesses going forward.' 'With a strong balance sheet, we are well-positioned to win new gas conversions, plant upgrades and behind-the-meter data center projects in North America and beyond,' Young added. 'We're also seeing additional demand for our BrightLoop™ technologies – both for steam generation and hydrogen production that can produce energy with lower costs and expenditures than other hydrogen technologies. Our unique technology – which is capable of supporting utilities and industries with low-cost hydrogen and steam generation while capturing CO 2 – demonstrates the spirit of innovation and strong engineering capabilities that have driven B&W throughout its history and will be the foundation of our growth strategy for years to come.' 'Diamond Power provides boiler cleaning and monitoring solutions for utilities and industries around the world, and we're grateful for the decades of hard work and dedication shown by its employees,' said Christopher Riker, B&W Executive Vice President and Chief Operating Officer. 'We look forward to working closely with ANDRITZ to ensure a smooth transition and to our continued collaboration on boiler cleaning solutions in the future.' About Babcock & Wilcox Headquartered in Akron, Ohio, Babcock & Wilcox Enterprises, Inc. is a leader in energy and environmental products and services for power and industrial markets worldwide. Follow us on LinkedIn and learn more at Forward-Looking Statements B&W cautions that this release contains forward-looking statements, including, without limitation, statements relating to an agreement to sell its Diamond Power businesses to ANDRITZ, demand for our products, future projects, and growth strategy. These forward-looking statements are based on management's current expectations and involve a number of risks and uncertainties. For a more complete discussion of these risk factors, see our filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K. If one or more of these risks or other risks materialize, actual results may vary materially from those expressed. We caution readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and we undertake no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.
